Yet the prevailing narrative continues to frame private capital as hesitant. This is a misdiagnosis. From an institutional investor perspective, the binding constraint is rarely risk appetite. It is ...

A new class of AI-native infrastructure companies is emerging to structure data for machine use—signaling that in the AI era, ...

Money Solves Problems. It Doesn’t Build Systems. Capital matters. It funds growth. It unlocks opportunities. It gives businesses room to move. But capital alone does not build a business. Many ...

Sandon Capital has long held a position in the fund management giant, which has proposed an increasing controversial $1.6 ...

Is Wall Street underestimating private capital’s problems? One top credit hedge fund boss thinks so, writes Amelia Pollard. The private capital industry’s problems exceed Wall Street’s expectations ...

CBL & Associates Properties stock has recovered from early 2026 weakness and is again outperforming U.S. REIT peers. This ...

A C-suite executive retiring at 62 with $1.8 million in a traditional 401(k), $400,000 in RSUs, a nonqualified deferred ...

By Augustina Ekua MILLS, Gideon BOSOMPIM & Esther ADDEI In recent years, the global economy has been hit hard by multiple crises, such as the COVID-19 pandemic and geopolitical tensions. These events ...

Much of the capital needed to fund resilience is domestic, patient and already looking for infrastructure exposure.

A state-controlled board designed to direct Nashville’s tourist tax dollars to multiple projects will work under the ...

Ratio is GAAP profitable, ensuring long-term platform stability for scale-ups Ratio Raises $15.8M to accelerate product roadmap with AI agents Ratio secures $100M in lending capacity to pay sellers ...

Organon is an American pharmaceutical company spun off from Merck & Co. in 2021 with a focus on women’s health, biosimilars, and established brands. Headquartered in Jersey City, it markets a ...